Wall Street brokerages expect Determine Inc (NASDAQ:DTRM) to report earnings per share of ($0.10) for the current quarter, according to Zacks. Two analysts have issued estimates for Determine’s earnings. Determine reported earnings per share of ($0.04) in the same quarter last year, which would suggest a negative year over year growth rate of 150%. The company is scheduled to issue its next earnings report on Thursday, June 14th.
On average, analysts expect that Determine will report full year earnings of ($0.37) per share for the current financial year. For the next financial year, analysts expect that the firm will report earnings of ($0.38) per share. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side analysts that cover Determine.
Determine (NASDAQ:DTRM) last announced its earnings results on Thursday, February 8th. The technology company reported ($0.09) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.12) by $0.03. Determine had a negative net margin of 30.59% and a negative return on equity of 87.88%. The business had revenue of $7.50 million for the quarter, compared to analyst estimates of $7.00 million. During the same quarter last year, the business earned ($0.08) earnings per share. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year.
Shares of Determine (DTRM) traded up $0.10 during midday trading on Wednesday, hitting $1.67. 24,290 shares of the stock traded hands, compared to its average volume of 23,214. Determine has a 1-year low of $1.23 and a 1-year high of $3.93. The firm has a market capitalization of $24.65, a price-to-earnings ratio of -13.75 and a beta of 1.55. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 1.09.
In other news, major shareholder Lloyd I. Miller III sold 62,000 shares of the firm’s stock in a transaction dated Tuesday, December 26th. The shares were sold at an average price of $1.73, for a total value of $107,260.00. Following the transaction, the insider now directly owns 250,820 shares of the company’s stock, valued at $433,918.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, major shareholder Lloyd I. Miller III sold 25,000 shares of the firm’s stock in a transaction dated Thursday, December 28th. The stock was sold at an average price of $1.69, for a total transaction of $42,250.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 112,000 shares of company stock worth $191,760. Insiders own 9.96% of the company’s stock.
An institutional investor recently bought a new position in Determine stock. Cornerstone Capital Inc. purchased a new position in Determine Inc (NASDAQ:DTRM) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 80,000 shares of the technology company’s stock, valued at approximately $144,000. Cornerstone Capital Inc. owned approximately 0.54% of Determine at the end of the most recent quarter. Hedge funds and other institutional investors own 18.34% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This report was originally reported by Ticker Report and is the property of of Ticker Report. If you are viewing this report on another publication, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this report can be viewed at https://www.tickerreport.com/banking-finance/3257990/determine-inc-dtrm-expected-to-post-earnings-of-0-10-per-share.html.
Determine Company Profile
Determine, Inc, (Determine), formerly Selectica, Inc, is a provider of enterprise contract management, supply management and configuration solutions. The Company is engaged in providing software as a service (SaaS) Source to Pay and Enterprise Contract Lifecyclem Management (ECLM) solutions. Its Source to Pay software suite includes strategic sourcing, supplier management, contract management and procure-to-pay applications.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Determine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Determine and related companies with MarketBeat.com's FREE daily email newsletter.